Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.97 EUR
310.30 M EUR
6.51 B EUR
127.80 M
About EUROFINS SCIENT.
Sector
CEO
Gilles G. Martin
Website
Headquarters
Luxembourg
Founded
2012
ISIN
FR0014000MR3
FIGI
BBG000BH7B07
Eurofins Scientific SE engages in the bio-analytical testing of food, environment, and pharmaceuticals products. The firm offers testing and laboratory services for agro science, genomics, discovery pharmacology and for supporting clinical studies. It operates through the following geographical segments: Europe, North America, and Rest of the World. The company was founded by Gilles G. Martin in 1987 and is headquartered in Luxembourg.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ERF is 47.96 EUR — it has increased by 0.59% in the past 24 hours. Watch EUROFINS SCIENT. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange EUROFINS SCIENT. stocks are traded under the ticker ERF.
ERF stock has fallen by −0.33% compared to the previous week, the month change is a 4.81% rise, over the last year EUROFINS SCIENT. has showed a −18.35% decrease.
We've gathered analysts' opinions on EUROFINS SCIENT. future price: according to them, ERF price has a max estimate of 90.00 EUR and a min estimate of 42.00 EUR. Watch ERF chart and read a more detailed EUROFINS SCIENT. stock forecast: see what analysts think of EUROFINS SCIENT. and suggest that you do with its stocks.
ERF stock is 2.17% volatile and has beta coefficient of 0.97. Track EUROFINS SCIENT. stock price on the chart and check out the list of the most volatile stocks — is EUROFINS SCIENT. there?
Today EUROFINS SCIENT. has the market capitalization of 9.18 B, it has decreased by −0.88% over the last week.
Yes, you can track EUROFINS SCIENT. financials in yearly and quarterly reports right on TradingView.
EUROFINS SCIENT. is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
ERF earnings for the last half-year are 1.64 EUR per share, whereas the estimation was 1.48 EUR, resulting in a 10.77% surprise. The estimated earnings for the next half-year are 1.56 EUR per share. See more details about EUROFINS SCIENT. earnings.
EUROFINS SCIENT. revenue for the last half-year amounts to 3.42 B EUR, despite the estimated figure of 3.47 B EUR. In the next half-year revenue is expected to reach 3.60 B EUR.
ERF net income for the last half-year is 220.70 M EUR, while the previous report showed 158.80 M EUR of net income which accounts for 38.98% change. Track more EUROFINS SCIENT. financial stats to get the full picture.
Yes, ERF dividends are paid annually. The last dividend per share was 0.50 EUR. As of today, Dividend Yield (TTM)% is 1.04%. Tracking EUROFINS SCIENT. dividends might help you take more informed decisions.
EUROFINS SCIENT. dividend yield was 0.85% in 2023, and payout ratio reached 31.09%. The year before the numbers were 1.49% and 31.55% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 21, 2024, the company has 61.80 K employees. See our rating of the largest employees — is EUROFINS SCIENT. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EUROFINS SCIENT. EBITDA is 1.34 B EUR, and current EBITDA margin is 18.59%. See more stats in EUROFINS SCIENT. financial statements.
Like other stocks, ERF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EUROFINS SCIENT. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EUROFINS SCIENT. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EUROFINS SCIENT. stock shows the sell signal. See more of EUROFINS SCIENT. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.